Andere talen AstraZeneca Pharma India Limited

Aandelen

ASTRAZEN

INE203A01020

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:54 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6.240 ^INR	-2,04%		-2,12%	+13,05%

21/06	AstraZeneca Pharma slaagt er niet in koper te vinden voor productielocatie in Bangalore, India	MT
01/06	Astrazeneca Pharma India Limited benoemt Shikha Mirchandani Chatrath tot Directeur - Commercial Excellence, BD & Strategy, met ingang van 17 juni 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AstraZeneca Pharma Fails to Find Buyer for Manufacturing Site in Bangalore, India	21/06
Astrazeneca Pharma India Limited Appoints Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy, Effective June 17, 2024	01/06
Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	28/05
AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director	27/05
Astrazeneca Pharma India Limited Recommends Dividend for the Financial Year 2023-24	27/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets	21/05
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	08/04
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	25/03
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11/03
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11/03
Astrazeneca Pharma India Limited Announces Board Changes	20/02
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
AstraZeneca Pharma India Limited Announces Board Changes	08/02
AstraZeneca Pharma India Limited Announces Directorate Appointments	07/02
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	22/01
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	21/12
India's Nifty set for muted open after steep drop	21/12
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen AstraZeneca Pharma India Limited

Aandelen

ASTRAZEN

INE203A01020

Andere talen

Filters